Gilead Sciences Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
99 result(s) found, displaying 51 to 60
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Remdesivir
-
Prescription medicine decision summaryTGA decision: Veklury (remdesivir) is provisionally approved to treat Coronavirus Disease 2019 (COVID-19) in adults and adolescents
-
Prescription medicine registrationActive ingredients: remdesivir.
-
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VOSEVI sofosbuvir (400 mg), velpatasvir (100 mg), voxilaprevir (100 mg) tablet bottle.
-
Prescription medicine registrationActive ingredients: T Cells - axicabtagene ciloleucel, cryopreserved - T - Yescarta.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VEMLIDY tenofovir alafenamide (as fumarate) 25 mg tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EPCLUSA sofosbuvir 400 mg / velpatasvir 100 mg tablet bottle.
-
Cancellation by sponsorRequested by Gilead Sciences Pty Ltd
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment for Sofosbuvir / Velpatasvir / Voxilaprevir